OKYO Pharma Ltd ADR
Price & Volume
Stats
See more52W Range | $1.28-$3.20 |
Market Cap | $69.2M |
Shares Short | 54,269 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$6.6M |
Diluted EPS | -$0.24 |
News
See moreYahoo Finance • 2 months ago
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Yahoo Finance • 2 months ago
OKYO Pharma Announces Purchase of Shares by Chairman
Yahoo Finance • 2 months ago
OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans
Yahoo Finance • 5 months ago
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
About
CEO | Mr. Robert J. Dempsey M.B.A. |
Address | 35a Albemarle St, London, United Kingdom, W1S 4JE |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |